Linking actin dynamics and gene transcription to drive cellular motile functions

Le Clainche, C. & Carlier, M. F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol. Rev. 88, 489–513 (2008).

Jaffe, A. B. & Hall, A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247–269 (2005).

Pollard, T. D. Regulation of actin filament assembly by Arp2/3 complex and formins. Annu. Rev. Biophys. Biomol. Struct. 36, 451–477 (2007).

Allingham, J. S., Klenchin, V. A. & Rayment, I. Actin-targeting natural products: structures, properties and mechanisms of action. Cell. Mol. Life Sci. 63, 2119–2134 (2006).

Cotton, M. & Claing, A. G protein-coupled receptors stimulation and the control of cell migration. Cell. Signal. 21, 1045–1053 (2009).

Iguchi, T. et al. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a Gα12/13 and Rho pathway. J. Biol. Chem. 283, 14469–14478 (2008).

Descot, A. et al. Negative regulation of the EGFR-MAPK cascade by actin-MAL-mediated Mig6/Errfi-1 induction. Mol. Cell 35, 291–304 (2009).

Lockman, K. et al. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 279, 42422–42430 (2004).

Schiller, M. R. Coupling receptor tyrosine kinases to Rho GTPases — GEFs what's the link. Cell. Signal. 18, 1834–1843 (2006).

Chai, J., Jones, M. K. & Tarnawski, A. S. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. Faseb J. 18, 1264–1266 (2004).

Knoll, B. et al. Serum response factor controls neuronal circuit assembly in the hippocampus. Nature Neurosci. 9, 195–204 (2006). This paper shows for the first time the essential role of SRF-controlled actin dynamics for the regulation of mouse neuronal development, neurite outgrowth and axonal guidance. See also references 12 and 13.

Stern, S. et al. A nuclear actin function regulates neuronal motility by serum response factor-dependent gene transcription. J. Neurosci. 29, 4512–4518 (2009).

Wickramasinghe, S. R. et al. Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron 58, 532–545 (2008).

Franco, C. A. et al. Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev. Cell 15, 448–461 (2008).

Holtz, M. L. & Misra, R. P. Endothelial-specific ablation of serum response factor causes hemorrhaging, yolk sac vascular failure, and embryonic lethality. BMC Dev. Biol. 8, 65–78 (2008).

Knoll, B. & Nordheim, A. Functional versatility of transcription factors in the nervous system: the SRF paradigm. Trends Neurosci. 32, 432–442 (2009).

Huveneers, S. & Danen, E. H. Adhesion signaling — crosstalk between integrins, Src and Rho. J. Cell Sci. 122, 1059–1069 (2009).

Zhao, X. H. et al. Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 120, 1801–1809 (2007).

Moustakas, A. & Heldin, C. H. Dynamic control of TGF-β signaling and its links to the cytoskeleton. FEBS Lett. 582, 2051–2065 (2008).

Fan, L. et al. Cell contact-dependent regulation of epithelial-myofibroblast transition via the Rho–Rho kinase–phospho-myosin pathway. Mol. Biol. Cell 18, 1083–1097 (2007).

Hinson, J. S., Medlin, M. D., Lockman, K., Taylor, J. M. & Mack, C. P. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am. J. Physiol. Heart Circ. Physiol. 292, H1170–H1180 (2007).

Morita, T., Mayanagi, T. & Sobue, K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol. 179, 1027–1042 (2007).

Lagna, G. et al. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J. Biol. Chem. 282, 37244–37255 (2007).

Busche, S., Descot, A., Julien, S., Genth, H. & Posern, G. Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling. J. Cell Sci. 121, 1025–1035 (2008).

Sebe, A. et al. Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor. FEBS Lett. 582, 291–298 (2008).

Perez-Moreno, M. & Fuchs, E. Catenins: keeping cells from getting their signals crossed. Dev. Cell 11, 601–612 (2006).

Winter, C. G. et al. Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell 105, 81–91 (2001).

Lai, S. L., Chien, A. J. & Moon, R. T. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res. 19, 532–545 (2009).

Simons, M. & Mlodzik, M. Planar cell polarity signaling: from fly development to human disease. Annu. Rev. Genet. 42, 517–540 (2008).

Roszko, I., Sawada, A. & Solnica-Krezel, L. Regulation of convergence and extension movements during vertebrate gastrulation by the Wnt/PCP pathway. Semin. Cell Dev. Biol. 20, 986–997 (2009).

Gieni, R. S. & Hendzel, M. J. Actin dynamics and functions in the interphase nucleus: moving toward an understanding of nuclear polymeric actin. Biochem. Cell Biol. 87, 283–306 (2009).

Zheng, B., Han, M., Bernier, M. & Wen, J. K. Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression. FEBS J. 276, 2669–26685 (2009).

Coso, O. A. et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81, 1137–1146 (1995).

Minden, A., Lin, A., Claret, F. X., Abo, A. & Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81, 1147–1157 (1995).

Rosso, S. B., Sussman, D., Wynshaw-Boris, A. & Salinas, P. C. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nature Neurosci. 8, 34–42 (2005).

Teramoto, H. et al. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J. Biol. Chem. 271, 27225–27228 (1996).

Marinissen, M. J. et al. The small GTP-binding protein RhoA regulates c-Jun by a ROCK-JNK signaling axis. Mol. Cell 14, 29–41 (2004).

Girardin, S. E. & Yaniv, M. A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation. EMBO J. 20, 3437–3446 (2001).

Fazal, F. et al. Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells. J. Biol. Chem. 284, 21047–21056 (2009).

Cowell, C. F. et al. Loss of cell-cell contacts induces NF-κB via RhoA-mediated activation of protein kinase D1. J. Cell Biochem. 106, 714–728 (2009).

Coutts, A. S., Weston, L. & La Thangue, N. B. A transcription co-factor integrates cell adhesion and motility with the p53 response. Proc. Natl Acad. Sci. USA 106, 19872–19877 (2009).

Zuchero, J. B., Coutts, A. S., Quinlan, M. E., Thangue, N. B. & Mullins, R. D. p53-cofactor JMY is a multifunctional actin nucleation factor. Nature Cell Biol. 11, 451–459 (2009).

Kremer, B. E., Adang, L. A. & Macara, I. G. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 130, 837–850 (2007).

Hervy, M., Hoffman, L. & Beckerle, M. C. From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr. Opin. Cell Biol. 18, 524–532 (2006).

Kadrmas, J. L. & Beckerle, M. C. The LIM domain: from the cytoskeleton to the nucleus. Nature Rev. Mol. Cell Biol. 5, 920–931 (2004).

Chang, D. F. et al. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4, 107–118 (2003).

Philippar, U. et al. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol. Cell 16, 867–880 (2004).

Schratt, G. et al. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J. Cell Biol. 156, 737–750 (2002). Using SRF-deficient embryonic stem cells, this paper uncovers the essential function of SRF in the control of actin cytoskeletal assembly, cell migration and cell adhesion.

Hill, C. S., Wynne, J. & Treisman, R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159–1170 (1995). This paper describes for the first time that SRF is a nuclear target of Rho-mediated signalling.

Posern, G., Sotiropoulos, A. & Treisman, R. Mutant actins demonstrate a role for unpolymerized actin in control of transcription by serum response factor. Mol. Biol. Cell 13, 4167–4178 (2002).

Sotiropoulos, A., Gineitis, D., Copeland, J. & Treisman, R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159–169 (1999). This paper reveals the regulation of SRF activity by G-actin and actin dynamics, consistent with the subsequent discovery that MRTFs are a key intermediary between actin dynamics and SRF activation. See also references 50, 74 and 75.

Miralles, F., Posern, G., Zaromytidou, A. I. & Treisman, R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329–342 (2003). This important paper shows that MRTF-A binds monomeric G-actin in the cytoplasm through the N-terminal RPEL motifs and translocates to the nucleus to interact with SRF in response to actin polymerization. See also reference 128.

Norman, C., Runswick, M., Pollock, R. & Treisman, R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-Fos serum response element. Cell 55, 989–1003 (1988). This paper describes the initial cloning of SRF and its mechanism of action as a dimeric transcriptional activator through binding to the CArG box DNA motif.

Shore, P. & Sharrocks, A. D. The MADS-box family of transcription factors. Eur. J. Biochem. 229, 1–13 (1995).

Pellegrini, L., Tan, S. & Richmond, T. J. Structure of serum response factor core bound to DNA. Nature 376, 490–498 (1995).

Treisman, R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46, 567–574 (1986). This report describes for the first time the binding of a transcription factor, later identified as SRF (see reference 53), to the c-fos transcriptional regulatory element termed SRE.

Miano, J. M., Long, X. & Fujiwara, K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292, C70–C81 (2007).

Posern, G. & Treisman, R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16, 588–596 (2006).

Selvaraj, A. & Prywes, R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol. Biol. 5, 13–28 (2004).

Sun, Q. et al. Defining the mammalian CArGome. Genome Res. 16, 197–207 (2006).

Stritt, C. et al. Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression. Nature Neurosci. 12, 418–427 (2009).

Shaw, P. E., Schroter, H. & Nordheim, A. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-Fos promoter. Cell 56, 563–572 (1989). This is the first report of SRF recruiting a cofactor (named TCF) to regulate target gene activity.

Buchwalter, G., Gross, C. & Wasylyk, B. Ets ternary complex transcription factors. Gene 324, 1–14 (2004).

Dalton, S. & Treisman, R. Characterization of SAP-1, a protein recruited by serum response factor to the c-Fos serum response element. Cell 68, 597–612 (1992).

Hipskind, R. A., Rao, V. N., Mueller, C. G., Reddy, E. S. & Nordheim, A. Ets-related protein Elk-1 is homologous to the c-Fos regulatory factor p62TCF. Nature 354, 531–534 (1991).

Parmacek, M. S. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ. Res. 100, 633–644 (2007).

Pipes, G. C., Creemers, E. E. & Olson, E. N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20, 1545–1556 (2006).

Wang, D. et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851–862 (2001). This important paper reports the discovery of myocardin, the founding member of the myocardin family of co-activators and a powerful activator of SRF-dependent transcription in cardiac muscle cells.

Wang, D. Z. et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl Acad. Sci. USA 99, 14855–14860 (2002). This paper reports the identification, structure, function and expression of MRTF-A and MRTF-B, showing their ability to act as potent co-activators of SRF.

Gineitis, D. & Treisman, R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276, 24531–24539 (2001).

Wang, Z. et al. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428, 185–189 (2004).

Zaromytidou, A. I., Miralles, F. & Treisman, R. MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNA-binding domain. Mol. Cell. Biol. 26, 4134–4148 (2006).

Arsenian, S., Weinhold, B., Oelgeschlager, M., Ruther, U. & Nordheim, A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17, 6289–6299 (1998). Through the creation of SRF-deficient embryos, this paper shows for the first time that SRF is essential for mesoderm formation during embryogenesis, probably reflecting in part its requisite role for the activation of cytoskeletal gene expression and cell migration.

Guettler, S., Vartiainen, M. K., Miralles, F., Larijani, B. & Treisman, R. RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Mol. Cell. Biol. 28, 732–742 (2008).

Posern, G., Miralles, F., Guettler, S. & Treisman, R. Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL. EMBO J. 23, 3973–3983 (2004).

Vartiainen, M. K., Guettler, S., Larijani, B. & Treisman, R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316, 1749–1752 (2007). This manuscript describes a role for nuclear G-actin in regulating the activity of nuclear MRTF.

Mouilleron, S., Guettler, S., Langer, C. A., Treisman, R. & McDonald, N. Q. Molecular basis for G-actin binding to RPEL motifs from the serum response factor coactivator MAL. EMBO J. 27, 3198–3208 (2008).

Kuwahara, K., Barrientos, T., Pipes, G. C., Li, S. & Olson, E. N. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol. Cell. Biol. 25, 3173–3181 (2005).

Wang, Z., Wang, D. Z., Pipes, G. C. & Olson, E. N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl Acad. Sci. USA 100, 7129–7134 (2003). This paper shows that myocardin acts as a master regulator of smooth muscle gene expression and can reprogramme fibroblasts to adopt a smooth muscle fate. See also references 104–106.

Huang, J. et al. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J. Clin. Invest. 118, 515–525 (2008).

Huang, J. et al. Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc. Natl Acad. Sci. USA 106, 18734–18739 (2009).

Li, S., Wang, D. Z., Wang, Z., Richardson, J. A. & Olson, E. N. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl Acad. Sci. USA 100, 9366–9370 (2003).

Sun, Y. et al. Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function. Mol. Cell. Biol. 26, 5809–5826 (2006).

Li, S., Chang, S., Qi, X., Richardson, J. A. & Olson, E. N. Requirement of a myocardin-related transcription factor for development of mammary myoepithelial cells. Mol. Cell. Biol. 26, 5797–5808 (2006).

Oh, J., Richardson, J. A. & Olson, E. N. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc. Natl Acad. Sci. USA 102, 15122–15127 (2005).

Muehlich, S. et al. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Mol. Cell. Biol. 28, 6302–6313 (2008).

Kalita, K., Kharebava, G., Zheng, J. J. & Hetman, M. Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity. J. Neurosci. 26, 10020–10032 (2006).

Kuwahara, K. et al. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J. Clin. Invest. 117, 1324–1334 (2007).

Chen, C. Y. & Schwartz, R. J. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol. Cell. Biol. 16, 6372–6384 (1996).

Belaguli, N. S. et al. Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol. Cell. Biol. 20, 7550–7558 (2000).

Sepulveda, J. L., Vlahopoulos, S., Iyer, D., Belaguli, N. & Schwartz, R. J. Combinatorial expression of GATA4, Nkx2–5, and serum response factor directs early cardiac gene activity. J. Biol. Chem. 277, 25775–25782 (2002).

Neuman, N. A. et al. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone. J. Biol. Chem. 284, 13202–13212 (2009).

Davis, F. J., Gupta, M., Camoretti-Mercado, B., Schwartz, R. J. & Gupta, M. P. Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J. Biol. Chem. 278, 20047–20058 (2003).

Hayashi, K., Nakamura, S., Nishida, W. & Sobue, K. Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription. Mol. Cell. Biol. 26, 9456–9470 (2006).

Liu, Y. et al. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 280, 9719–9727 (2005).

Chen, F. et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713–723 (2002).

Kook, H. et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein HOP. J. Clin. Invest. 112, 863–871 (2003).

Shin, C. H. et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110, 725–735 (2002).

Cao, D. et al. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25, 364–376 (2005).

Hanna, M. et al. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J. Biol. Chem. 284, 23125–23136 (2009).

Qiu, P. et al. Myocardin enhances Smad3-mediated transforming growth factor-β1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22α transcription in vivo. Circ. Res. 97, 983–991 (2005).

Oh, J. et al. Target gene-specific modulation of myocardin activity by GATA transcription factors. Mol. Cell. Biol. 24, 8519–8528 (2004).

Cooper, S. J., Trinklein, N. D., Nguyen, L. & Myers, R. M. Serum response factor binding sites differ in three human cell types. Genome Res. 17, 136–144 (2007).

Chen, J., Kitchen, C. M., Streb, J. W. & Miano, J. M. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34, 1345–1356 (2002).

Du, K. L. et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol. 23, 2425–2437 (2003).

Yoshida, T. et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92, 856–864 (2003).

Du, K. L. et al. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J. Biol. Chem. 279, 17578–17586 (2004).

Li, S. et al. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl Acad. Sci. USA 102, 1082–1087 (2005).

Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E. & Treisman, R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nature Cell Biol. 11, 257–268 (2009).

Verdoni, A. M., Aoyama, N., Ikeda, A. & Ikeda, S. Effect of destrin mutations on the gene expression profile in vivo. Physiol. Genomics 34, 9–21 (2008).

Niu, Z., Li, A., Zhang, S. X. & Schwartz, R. J. Serum response factor micromanaging cardiogenesis. Curr. Opin. Cell Biol. 19, 618–627 (2007).

Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214–220 (2005). This paper shows for the first time that SRF regulates the expression of miRNAs. The identified miRNA, miR-1, controls cardiomyocyte proliferation.

Liu, N. et al. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242–3254 (2008). This paper shows that the miRNA miR-133a is required for cardiac development and negatively regulates SRF. See also reference 116.

Ivey, K. N. et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2, 2192–29 (2008).

Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166–2178 (2009). This paper shows that SRF, together with members of the myocardin family, directly activates a bicistronic cluster of miRNAs, encoding miR-143 and miR-145, which in turn control smooth muscle phenotype switching through the regulation of numerous regulators of actin dynamics. See also references 117 and 118.

Niu, Z. et al. Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart. Proc. Natl Acad. Sci. USA 105, 17824–17829 (2008).

Cordes, K. R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705–710 (2009).

Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634–2647 (2009).

Small, E. M. et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc. Natl Acad. Sci. USA. 107, 4218–4223 (2010).

Torrado, M. et al. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J. Mol. Med. 81, 566–577 (2003).

Xing, W. et al. Myocardin induces cardiomyocyte hypertrophy. Circ. Res. 98, 1089–1097 (2006).

Chang, J. et al. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 108, 407–413 (2003).

Chow, N. et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc. Natl Acad. Sci. USA 104, 823–828 (2007).

Bell, R. D. et al. SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells. Nature Cell Biol. 11, 143–153 (2009).

Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767–801 (2004).

Carroll, A. et al. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a pediatric oncology group study. Blood 78, 748–752 (1991).

Ma, Z. et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nature Genet. 28, 220–221 (2001).

Mercher, T. et al. Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7. Genes Chromosomes Cancer 33, 22–28 (2002).

Cen, B. et al. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol. Cell. Biol. 23, 6597–6608 (2003).

Descot, A. et al. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression. Mol. Cell. Biol. 28, 6171–6181 (2008).

Sawada, T. et al. Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity. J. Biol. Chem. 283, 26820–26828 (2008).

Mercher, T. et al. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. J. Clin. Invest. 119, 852–864 (2009).

Milyavsky, M. et al. Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. Cancer Cell 11, 133–146 (2007).

Perot, G. et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res. 69, 2269–2278 (2009).

Heemers, H. V., Regan, K. M., Dehm, S. M. & Tindall, D. J. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. Cancer Res. 67, 10592–10599 (2007).

Brandt, D. T. et al. SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of β1-integrin. Nature Cell Biol. 11, 557–568 (2009). This paper uncovers a role for MRTF in the control of cancer cell metastasis as a consequence of its regulation by SCAI, a transcriptional repressor that competes with MRTF for interaction with SRF. See also reference 109.

Parlakian, A. et al. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol. Cell. Biol. 24, 5281–5289 (2004).

Miano, J. M. et al. Restricted inactivation of serum response factor to the cardiovascular system. Proc. Natl Acad. Sci. USA 101, 17132–17137 (2004).

Alberti, S. et al. Neuronal migration in the murine rostral migratory stream requires serum response factor. Proc. Natl Acad. Sci. USA 102, 6148–6153 (2005).

Ramanan, N. et al. SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nature Neurosci. 8, 759–767 (2005).

Bhavsar, A. P., Guttman, J. A. & Finlay, B. B. Manipulation of host-cell pathways by bacterial pathogens. Nature 449, 827–834 (2007).

Chhabra, E. S. & Higgs, H. N. The many faces of actin: matching assembly factors with cellular structures. Nature Cell Biol. 9, 1110–1121 (2007).